Introduction
Male infertility affects up to 12% of men (Lotti and Maggi, 2018) . Its aetiology is related to pre-testicular, testicular or post-testicular causes. Of post-testicular factors, antisperm antibodies (ASA) are involved in immunological infertility (Tuttelman and Nieschlag, 2010; Jungwirth et al., 2018) .
ASA are immunoglobulins directed against antigens of the sperm surface (Mazumdar and Levine, 1998; Restrepo and Cardona-Maya, 2013; Vazquez-Levin et al., 2014) . They can be found in blood serum and in seminal fluid, either free or bound to spermatozoa (Cui et al., 2015) . They belong mainly to IgG and IgA classes, while IgM are rarely found (Vazquez-Levin et al., 2014) .
The prevalence of ASA varies depending on the screening method (Lombardo et al., 2001; Francavilla et al., 2007; Vazquez-Levin et al., 2014) . Infertile men show a wide range of ASA detection (3.9-15.6%) (Sinisi et al., 1993; WHO, 1987; Pierik et al., 2000; Tuttelmann and Nieschlag, 2010; Bozhedomov et al., 2015; Jungwirth et al., 2018) , with significantly higher rates than those reported in fertile men (0.9-2.5%) (Sinisi et al., 1993; Heidenreich et al., 1994; Bozhedomov et al., 2015) .
The WHO (2010) suggests two direct tests to detect ASA on spermatozoa, the mixed antiglobulin reaction (MAR) test and the immunobead test. The latter has been recently curtailed by the manufacturer (Bollendorf and Check, 2016) . The former is widely used, shows good diagnostic accuracy (Mahmoud and Comhaire, 2000; Verón et al., 2016) , and is related to achievement of spontaneous pregnancy (Leushuis et al., 2009) . The WHO (2010) suggests a pathological threshold of ≥50% motile spermatozoa with adherent particles, because above this cut-off sperm penetration in cervical mucus and in-vivo fertilization tend to be impaired (Abshagen et al., 1998) .
ASA have been detected in men with a history of scrotal injury or post-testicular damage of the male genital tract (Mazumdar and Levine, 1998; Restrepo and Cardona-Maya, 2013; Vazquez-Levin et al., 2014) . Despite the wide literature on this topic, no study has reported ultrasound information on testicular or post-testicular alterations associated with ASA. The aim of this study was to evaluate correlations between ASA, as detected by the MAR test, and ultrasound characteristics of the entire male genital tract systematically, along with other clinical and seminal parameters.
Materials and methods
We studied a consecutive series of 699 male patients (mean age 37.0 ± 7.9 years) attending our outpatient clinic for the first time from September 2012 to September 2017, and seeking medical care for couple infertility, defined according to the WHO (2000) . As a control group, we evaluated 109 healthy, fertile men (mean age 36.6 ± 5.2 years) from a Florence spin-off ultrasound study on male fertility sponsored by the European Academy of Andrology (EAA; http://www.andrologyacademy.net/studies). Fertile men were defined as partners of women in the second or third trimester of pregnancy or who had fathered a child during the previous year by natural conception.
All subjects were evaluated before beginning any treatment. The data reported in this study for males of infertile couples were collected according to a 'Day Service' standard protocol, encoded by PACC L-99 (D/903/110 Azienda Ospedaliera-Universitaria Careggi [AOUC] , Florence, Italy) and approved by the Regional Health Care Service ( §DGRT n.1045; n.722; n.867), as previously described (Lotti et al., 2014a) . Data reported for fertile subjects were collected according to the EAA study protocol, approved by the Florence Ethical Committee (6 June 2013; Prot.2013/0024124) and the AOUC (11 November 2013; Prot.37896/2013, Rubrica n.60/13) , as previously described (Lotti et al., 2016a) . All subjects underwent the following routine procedures: medical history, physical examination, endocrine analysis, scrotal and transrectal colour-Doppler ultrasound evaluation and semen analysis. All subjects gave their written informed consent to have their clinical records included in a dedicated database and they were aware that their data, after having been made anonymous, would be used for clinical research.
Medical history, physical examination and life-style parameters
Medical history was investigated according to the European Urology Association guidelines (Jungwirth et al., 2018) . A complete physical examination and self-reported data on lifestyle (smoking habit and alcohol consumption) were assessed as reported in a previous study in the two cohorts.
Semen analysis and evaluation of MAR test, seminal interleukin 8 levels, urine and seminal cultures and endocrine parameters All subjects underwent, during the same morning of an ultrasound session, blood tests and semen analysis, the latter performed according to the WHO criteria (2010) and the Björndahl et al. (2016) checklist. The presence of antibodies coating spermatozoa was evaluated by a direct test using the commercial SpermMAR test IgG (FertiPro, Industriepark, Noord 32, Beernem, Belgium). A 5 μl semen sample was added to the same volume of IgG coated particle (beads) suspension and of antiserum against human IgG, then mixed with the pipette tip and the mixture was covered with a coverslip. After 3 and 10 min, the preparation was examined by phase-contrast microscopy at 400× magnification and the percentage of motile spermatozoa with attached beads was evaluated on at least 200 spermatozoa. The test was considered positive, according to WHO (2010) , if at least 50% motile spermatozoa showed adherent particles. In addition, the presence of any positivity (MAR test ≥ 1%) and percentage of positivity used as a continuous variable ('% MAR test positivity') were also recorded. The test was performed when a sperm concentration of >10 7 / ml and a forward progressive sperm motility of >10% were detected, as in a previous study (Cerasaro et al., 1985) .
Seminal plasma interleukin 8 (sIL-8) levels, a reliable surrogate marker of male genital tract inflammation , were measured according to a previous study (Lotti et al., 2011) . Urine and seminal cultures were performed in all subjects, as previously reported (Lotti et al., 2014a) , as infections of the male genitourinary tract could affect semen parameters.
Endocrine parameters were assessed as previously reported (Lotti et al., 2016a,b) .
Colour-Doppler ultrasound (CDUS)
All subjects underwent scrotal and transrectal CDUS before and after ejaculation, by using the ultrasonographic console MyLab Class C (Esaote SpA, Genova, Italy).
Scrotal CDUS was performed systematically as described in previous studies ) with a 7.5 MHz high-frequency linear probe (LA523 6-13 MHz). The measurement of the epididymal segments (head, body and tail) and detection of echotexture abnormalities were defined in line with previous studies (Lotti et al., 2011; and with the EAA study protocol (http://www.andrologyacademy.net/studies). Dilation of epididymal head and tail were defined as > 12 and 6 mm, respectively .
Prostate and seminal vesicles (SV) were studied as in previous studies (Lotti et al., 2014a,b) , by using a transrectal biplanar probe (linear transducer TRT33L 3-13 MHz; convex transducer TRT33C 3-13 MHz), and an 'end fire' probe (EC123 3-9 MHz, field of view 50−200°) to investigate SV better (Lotti et al., 2012) . Prostate and SV volume and CDUS features were defined as previously reported Maggi, 2012, 2015) .
Data analysis
Data were expressed as mean±SD when normally distributed, as medians (quartiles) for parameters with non-normal distribution, and as percentages when categorical. Statistical analyses were performed by evaluating (i) the percentage of spermatozoa showing attached particles, defined as '% MAR test positivity' (continuous variable), and (ii) the presence of a MAR test ≥ 1% (binary variable) and of (iii) MAR test ≥ 50% (binary variable).
Correlations were assessed using Spearman's or Pearson's method whenever appropriate. Unpaired two-sided Student's t tests were used for comparisons of means of normally distributed parameters; when distribution could be normalized through logarithmic transformation, the same test was applied to logarithmically transformed data. In all other cases, Mann-Whitney U-test was used for comparisons between groups. Relative risk and 95% confidence interval were calculated for association of categorical parameters, and Chi-squared test was used for comparisons.
Stepwise multiple linear, logistic binary or analysis of covariance (ANCOVA) with Bonferroni correction were applied for multivariate analyses, whenever appropriate. Multivariate analyses were performed by using two models: Model 1, adjusted for age, and Model 2, adjusted for age but also including alcohol consumption and smoking habit as further covariates. All statistical analysis was performed on SPSS (Statistical Package for the Social Sciences, Chicago, IL, USA) for Windows 20.0. A P < 0.05 was considered as significant. Associations of % MAR test positivity (percentage of spermatozoa showing attached particles) and comparisons between subjects with positive and negative MAR test were evaluated both in the entire sample (males of infertile couples + fertile men, n = 290) and in the two cohorts of males of infertile couples and fertile men.
Results

Out
Comparison between males of infertile and fertile couples A higher prevalence of any MAR test positivity (Fig. 1, panel A) and MAR test ≥ 50% (Fig. 1, panel B) was observed in males of infertile couples than in fertile men. These results were confirmed in a fully adjusted model (Model 2, .65], P = 0.018 and OR=9.16 [1.13-74.65], P = 0.038, respectively).
Supplementary Tables S1 and S2 show the other clinical and CDUS characteristics, respectively, of the entire sample, and comparisons between males of infertile and fertile couples. Males of infertile couples were older and declared less alcohol intake than fertile men, whereas no difference between groups was observed for smoking habits. Males of infertile couples more often reported a history of orchiopexy and had a lower mean testis volume, as assessed by both Prader orchidometer and CDUS, higher FSH levels and lower semen quality than fertile men. No other clinical difference was observed between groups. At CDUS, males of infertile couples showed testicular inhomogeneity and the presence of hydrocele more often than fertile men. In addition, they had higher epididymal and deferential diameters and more frequent epididymal inhomogeneity. Finally, they showed a higher prevalence of dilated ejaculatory ducts, inhomogeneity of the prostate and seminal vesicles, and a larger periprostatic venous plexus. All the previous associations were confirmed after adjusting for confounders (not shown). Tables I and II show the clinical (Table I) and CDUS (Table II) Tables I and II were further introduced in an ANCOVA model and adjusted for age (Model 1, Table III ) and for age and life-style (Model 2, Table III ). Table III also shows multivariate analyses of the significant associations between % MAR test positivity used as a continuous variable and the parameters investigated in Tables I and II, according 
Correlations of % MAR test and positive MAR test with clinical and ultrasound parameters
Socio-demographic, clinical and medical history-derived parameters
No correlations between % MAR test positivity and sociodemographic characteristics were observed (Table I) . Accordingly, no difference in age and life-style parameters were observed between men with and without a positive MAR test. Considering medical history, we found a higher % MAR test positivity in men with a history of epididymitis than the rest of the sample (Table I) , even after adjusting for confounders (Table III) . Conversely, no associations between % MAR test positivity and a history of scrotal or inguinal diseases or surgery (Table I) or inflammatory conditions of the distal genital tract (Table I) were observed. Furthermore, we found no associations between % MAR test positivity and several clinical parameters, including testis volume (assessed by both Prader orchidometer and CDUS) and the presence of varicocele (Table I) . Finally, no differences in the aforementioned parameters were observed when comparing subjects with a positive MAR test (≥1% or ≥50%) and the rest of the sample, except for a higher prevalence of history of epididymitis in men with MAR test ≥1% (Fig. 2 , panel A; Tables I and III) .
Similar results were observed considering only men with couple infertility (not shown), whereas no correlations with the aforementioned parameters were found in fertile men (not shown).
Seminal parameters. No correlations between % MAR test positivity
and seminal characteristics (Table I ) and no differences in seminal parameter values in subjects with positive MAR test (≥1% or ≥50%) and the rest of the sample (Table I) were observed. In addition, no correlations between MAR test positivity and positive urine or seminal cultures were detected. However, subjects with MAR test ≥ 1% showed high sIL-8 levels more often (i.e. sIL-8 >4545 pg/ml, a cut-off indicative of male genital tract inflammation) (Fig. 2 , panel B and Table I ). The latter association maintained significance after adjusting for age (Model 1, Table III ), but it was attenuated when alcohol and smoking habit were introduced in Model 2 (Table III) .
In males of infertile couples, only a negative association between % MAR test positivity and ejaculate volume was observed, however, it was not confirmed after adjusting for age (β = −0.143, P = 0.053). In fertile men, no correlations between % MAR test positivity and seminal parameters were found (not shown).
Endocrine parameters. Only a positive correlation between % MAR test positivity and LH levels was observed (Fig. 2 , panel C and Table I ), even after adjusting for confounders (Table III) . Accordingly, subjects with different positivity of MAR test (≥1% or ≥50%) showed higher LH levels than the rest of the sample (Tables I and III) . Conversely, the groups did not differ in other glycometabolic and hormonal parameter values, including FSH (Tables I), total (Table I ) and free testosterone (Fig. 2, panel D and Table I) .
Similar results were observed for men with couple infertility (not shown), while, in fertile men, only a positive association between % MAR test positivity and LH levels was observed (r = 0.224, P = 0.020), although the latter did not reach statistical significance when adjusted for confounders (β = 0.182; P = 0.061).
Colour-Doppler ultrasound (CDUS) parameters. Considering the scrotal region, no association between % MAR test positivity and testicular or pampiniform plexus CDUS parameters were observed. Conversely, we detected positive correlations between % MAR test positivity and the diameters of the epididymal segments (head, body and tail) and vas deferens ( Fig. 3 and Table II), even after adjusting for confounders (Table III) . In addition, % MAR test positivity was higher in subjects with inhomogeneous or hyperechoic epididymal echotexture than the rest of the sample (Table II) , even in adjusted models (Table III) . Accordingly, subjects with MAR test ≥1% showed a greater mean size of the epididymis and vas deferens and more frequent CDUS abnormalities of the epididymis than the rest of the sample 
Seminal parameters
Sexual abstinence (days) 4.3 ± 2.6 4.6 ± 2.8 4.3 ± 2.6 4.7 ± 3.5 r = 0.062, P = 0.295
Semen volume (ml) 3.6 ± 1.7 2.9 ± 1.6 3.6 ± 1.7 2.8 ± 1.6 r = −0.101, P = 0.087 pH 7.6 ± 0.2 7.6 ± 0.2 7.6 ± 0.2 7.7 ± 0.2 r = 0.027, P = 0. Major calcification size (mm) 4.3 ± 6.0 4.4 ± 5.5 4.3 ± 6.0 4.5 ± 5.7 r = 0.039, P = 0.532
Mean arterial peak systolic velocity (cm/s) 9.7 ± 5.9 9.2 ± 2.9 9.7 ± 5.8 9.4 ± 3.2 r = −0.023, P = 0.700
Mean prostatic venous plexus (mm) 3.8 ± 1.5 3.9 ± 1.5 3.8 ± 1.5 3.9 ± 1.5 r = 0.028, P = 0.639 
Epididymis and vas deferens
Mean size of the head (mm) 9.5 ± 1.6 10.7 ± 2.4**** 9.6 ± 1.7 10.5 ± 2.3 r = 0.131, P = 0.025
Mean size of the head >12 mm, % 6.8 29.1**** 7.9 23.1 RR = 1.02 [1.01-1.04], P = 0.007
Mean size of the body (mm) 4.0 ± 0.8 4.8 ± 0.9**** 4.0 ± 0.8 4.9 ± 1.1**** r = 0.248, P < 0.0001
Mean size of the tail (mm) 5.0 ± 0.9 6.2 ± 1.3**** 5.0 ± 1.0 6.2 ± 1.4*** r = 0.246, P < 0.0001
Mean size of the tail >6 mm, % 12.9 43.5**** 13.9 46.2** RR = 1.02 [1.01-1.04], P = 0.001
Mean size of the vas deferens (mm) 3.7 ± 0.7 4.4 ± 1.2* 3.7 ± 0.8 4.2 ± 0.9* r = 0.180, P = 0.002
Mean size of the deferential ampullae (mm) 4.6 ± 0.9 4.8 ± 1.2 4.6 ± 0.9 4.9 ± 1.4 r = 0.069, P = 0. . b Calculated from the 'ellipsoid/prolate (d1 > d2 = d3) spheroid' formula (d1*d2*d3*4/3*π, considering d1 = ½ maximum longitudinal diameter of the SV and both d2 and d3 = ½ anterior-posterior maximum diameter) (according to Lotti et al., 2012a) . c SV ejection fraction, calculated as [total SV volume before ejaculation -total SV volume after ejaculation]/total SV volume before ejaculation] × 100 (according to Lotti et al., 2012b) . d CDUS-defined severe varicocele = basal venous reflux increasing or not after Valsalva's manoeuvre at sonography (see . RR, relative risk. Comparisons between subjects with MAR test -and + and between subjects with MAR test < and ≥ 50% are reported: *P < 0.05, **P < 0.01 ***P < 0.005, ****P < 0.0001. Bold characters emphasize parameters significantly different among groups and significant associations of the % MAR test positivity with CDUS parameters. 
Multivariate analysis of the significant correlations of the % MAR test positivity reported in bold in Table I and II, adjusting for age (Model 1), and age, alcohol consumption and smoking habit (Model 2).
( Tables I and III ). In addition, considering the cut-off commonly used to indicate the dilation of the epididymal head and tail (diameter >6 and 12 mm, respectively), we found a higher frequency of these abnormalities in men with MAR test ≥1% (Tables II and III) . Of note, men with MAR test ≥50% had a larger epididymal body and tail and more often a dilated tail and hyperechoic texture than the rest of the sample (Tables I and III) . Considering the prostate-vesicular region, we found no association between % MAR test positivity or a positive MAR test (≥1% or >50%) and prostate CDUS parameter values (Table II) . Conversely, seminal vesicle volume before ejaculation showed a negative correlation with % MAR test positivity (Table II) , as it was lower in subjects with MAR test ≥1% than in the rest of the sample (Table II) . However, these associations were not confirmed after adjusting for age (data not shown).
Similar results were observed for men with couple infertility (not shown), while, in fertile men, only a positive association between % MAR test positivity and epididymal body and tail diameters (r = 0.248, P = 0.009 and r = 0.240, P = 0.012, respectively) was observed, and the latter maintained significance after adjusting for confounders (β = 0.204, P = 0.037).
Discussion
This is the first study to systematically investigate in males of infertile and fertile couples the associations between ASA, detected by the SpermMAR test IgG, and CDUS characteristics of the entire male genital tract, along with clinical and seminal parameters. Our main finding was a significant association between a positive MAR test and CDUS abnormalities of the epididymis suggestive of chronic inflammation, along with a history of epididymitis and high levels of sIL-8, a marker of genital tract inflammation. Conversely, MAR test positivity was not associated with CDUS features of other organs of the male genital tract, including the testis. Furthermore, MAR test positivity was associated with higher LH but not testosterone or FSH levels, suggesting partial damage to Leydig cells but not to the seminiferous tubules. Finally, although we found a positive MAR test more often in males of infertile couples than in fertile men, no association between MAR test positivity and conventional semen parameter values was observed.
The primary aim of this study was to evaluate correlations of SpermMAR test IgG and CDUS features of the male genital tract. The SpermMAR test is a simple, sensitive, specific and reliable assay for detecting ASA (Comhaire et al., 1988; WHO, 2010) . Several studies Figure 2 Comparison between men with any positive MAR test (MAR test +) and the rest of the sample (MAR test -) for history of epididymitis (A) and high seminal interleukin 8 (sIL-8; B) levels, and associations between % MAR test positivity, LH (C) and calculated free testosterone (D) levels. The results reported in panels A-D were derived from a statistical analysis performed on the entire sample (males of infertile and fertile couples, n = 290). In panel B, high sIL-8 levels were defined as sIL-8 > 4545 pg/ml, according to a previous study (Lotti et al., 2010) . In panels C and D, LH and calculated free testosterone levels are reported in quartiles for graphical purposes. LH, luteinizing hormone.
have demonstrated the diagnostic accuracy and the clinical significance of this test (Mahmoud and Comhaire, 2000; Verón et al., 2016; Leushuis et al., 2009) . We here originally report that subjects with a positive MAR test show several epididymal abnormalities at CDUS, such as dilation, inhomogeneity and hyperechogenicity. Of note, these CDUS abnormalities are suggestive of inflammation . MAR test positivity was not associated with epididymal hyperaemia at CDUS or positive urine or seminal cultures, which are parameters related to an acute inflammation (Pilatz et al., 2013) . In addition, subjects with positive MAR test frequently had a history of epididymitis and high sIL-8 levels, a marker of genital tract inflammation (Lotti et al., 2011; Maggi, 2013, 2015) . All these findings suggest that a chronic, rather than an acute, inflammation is associated with ASA positivity. However, this may also indicate that the SpermMAR test IgG detects a chronic more than an acute immune response, since IgG production follows acute IgM release and remains constant for a long time thereafter (Restrepo and Cardona-Maya, 2013 ). Of note, when an epididymal inflammation occurs, the tail is often affected (Hedger, 2011; Pilatz et al., 2013) . Accordingly, in our study, a larger epididymal tail was the parameter most strongly associated with MAR test positivity, both in males of infertile and fertile couples. MAR test positivity was not associated with CDUS abnormalities of other organs of the male genital tract, including the testis, nor with high FSH levels which would be suggestive of tubular damage. This result was surprising, since ASA detection has been reported in men with a history of testicular injury (Vazquez-Levin et al., 2014) . However, our data suggest that a testicular interstitial alteration is associated with ASA. In fact, LH levels are increased as a function of ASA positivity, indicating a partial impairment of Leydig cell function, because testosterone levels were not affected. Considering that Leydig cells represent less than 3% of the total testicular volume (Weinbauer et al., 2010) , their anatomical damage may not be detectable with CDUS.
Historically, the mechanism underlying the development of seminal ASA was related to an injury of the blood-testis barrier (BTB) Figure 3 Associations between % MAR test positivity and the mean diameter of the epididymal segments (head, A; body, B; tail, C) and of the vas deferens (D). The results reported in panels A-D were derived from a statistical analysis performed on the entire sample (males of infertile and fertile couples, n = 290). The mean size of the epididymal segments and of vas deferens is reported in quartiles for graphical purposes. (Francavilla et al., 2007; Mital et al., 2011; Vazquez-Levin et al., 2014) . The BTB plays a key role in the tolerance to sperm antigens, separating spermatozoa from the immune system, allowing the seminiferous tubules to be an immune-privileged site. A testicular injury leading to BTB disruption can expose sperm antigens to the immune cells, evoking an autoimmune response including ASA production (Weinbauer et al., 2010; Mital et al., 2011; Kaur et al., 2013; Vazquez-Levin et al., 2014) . BTB disruption may occur also in the proximal epididymal head, where the spermatozoa released from the rete testis enter the efferent ducts and the BTB terminates. This region is a weak transition zone made of Sertoli-like cells and macrophages, susceptible to inflammatory damage and therefore to ASA formation (Weinbauer et al., 2010; Hedger, 2011) . ASA can also be produced downstream from this region, where the epididymis is protected by the so-called bloodepididymal barrier (BEB) (Hedger, 2011; Mital et al., 2011; Gregory and Cyr, 2014) . First described by Friend and Gilula (1972) , the BEB consists of an anatomical, an immunological and a physiological barrier. The first two barriers are made of the tight junctions between the epididymal epithelial cells, while the third barrier is made of specific transporters located along these cells, regulating the movement of molecules in and out of the lumen (Hedger, 2011; Mital et al., 2011; Gregory and Cyr, 2014) . The epididymis is a highly specialized organ involved in the maturation, transport, protection and storage of sperm before ejaculation. The BEB is important in regulating the luminal microenvironment, allowing for sperm maturation, and separating sperm antigens from the immune system. While the BEB physiological barrier is more sophisticated than that of the BTB, its anatomical barrier is less effective, making the epididymis less immune-privileged and more susceptible to inflammation than the testis. Inflammation can result in the loss of BEB function, exposure of the maturing spermatozoa to the immune system and ASA production (Hedger, 2011; Mital et al., 2011; Gregory and Cyr, 2014) . Of note, the sperm autoantigen concentration in the epididymis equals or exceeds that in the testis, making the epididymis an elective site of an antisperm autoimmune response (Pöllänen and Cooper, 1994) . Furthermore, unlike seminiferous tubules, immune cells are common within the epididymal epithelium and interstitium and during inflammation their number and activity increase (Hedger, 2011) . In addition, the basal cells of the epididymis, showing similarities with macrophages (Yeung et al., 1994; Seiler et al., 1998) , could be involved in generating ASA, as occurs in a murine model of epididymal ligation (Seiler et al., 2000) , which could resemble chronic epididymal inflammation. Finally, dendritic cells, identified in human and mouse epididymis, play a complex role in the epididymal immune homoeostasis, showing tolerogenic, immunogenic or inflammatory properties according to their phenotype (Wang and Duan, 2016) .
Overall, our data support that ASA development does not depend just on a direct testicular injury, but is rather due to an epididymal inflammation, eventually extending to the testis and affecting Leydig cells. In fact, epididymitis involves the testis during inflammation in up to half of cases (Hedger, 2011; Pilatz et al., 2013; . Leydig cells are located in the testicular interstitium, which contains also immunocompetent cells (Weinbauer et al., 2010; Kaur et al., 2013) . When a testicular inflammation occurs, activated macrophages secrete inflammatory mediators that can impair Leydig cell steroidogenesis (Hales, 2002) and induce a counterbalancing LH increase. On the other hand, when testosterone levels are low, as demonstrated in castrated rats, the epididymal epithelium may leak allowing movement of IgG (Pollanen et al., 1995) . Hence, it could be speculated that partial Leydig cell impairment may lead to a decrease in local testosterone levels contributing to alter the BEB.
Our study also evaluated the relationship between MAR test positivity, semen parameters and fertility status. We found a higher prevalence of MAR test positivity in infertile than fertile men, in agreement with previous studies (Cerasaro et al., 1985; Comhaire et al., 1988; Sinisi et al., 1993; Bozhedomov et al., 2015) , confirming a role of ASA in infertility (WHO, 2000) . This result could rely on the fact that infertile men have epididymal abnormalities suggestive of a chronic inflammation more often, as we detected using CDUS. However, as the infertile men were older than the fertile men, even age could play a role in this context, since a longer life span could increase the probability of developing an epididymal inflammation leading to ASA onset. So far, studies assessing the impact of ASA on semen parameters, using different ASA detection methods and cut-offs, have shown contradictory results (Mazumdar and Levine, 1998; Francavilla et al., 2007) . In addition, a recent meta-analysis (Cui et al., 2015) reported a significant negative association of ASA and sperm concentration and progressive motility. However, the authors recognized several limitations, including heterogeneity in the methodology and cut-off values for ASA detection, small sample size and exclusion of several studies. Only two studies included in the aforementioned meta-analysis used the MAR test cut-off of 50%, as suggested by the WHO. One study (Garcia et al., 2007) , using MAR test IgG, found a significantly higher sperm concentration in ASA positive men, in contrast with the overall result of the meta-analysis. The second study (Zini et al., 2011a) , using MAR test IgG/IgA, reported no difference in sperm parameters between ASA positive and negative subjects. In line with the latter results, we found no associations between MAR test positivity and conventional semen parameters. These findings, taken together, suggest that ASA may affect fertility through mechanisms unrelated to conventional semen parameters, e.g. by reducing sperm cervical mucus penetration, capacitation, the acrosome reaction and sperm-oocyte binding and penetration (Lombardo et al., 2001; Francavilla et al., 2007; WHO, 2010) . However, studies investigating the relationship between ASA and spontaneous pregnancy rates show conflicting results (see, for review, Francavilla et al., 2007; Leushuis et al., 2009) . In addition, two recent meta-analyses (Zini et al., 2011a,b) , focused on IVF or ICSI-induced pregnancy, indicate that ASA positivity does not affect pregnancy outcomes.
The present study has some limitations. First, ASA-sperm complexes were detected in this study by using the MAR test, but other tests are available for ASA detection, and the results of the different tests do not always agree (WHO, 2010) . However, the SpermMAR test shows a high specificity when ≥40% motile spermatozoa with adherent particles are detected (Comhaire et al., 1988) , and a low percentage of positivity could underlie an unspecific reaction. In addition, we used SpermMAR test IgG that is unable to detect IgA antibodies, which may have a relevant clinical importance (WHO, 2010) . Furthermore, for technical reasons, the MAR test is not assessable in subjects with severe oligo-astheno-zoospermia and, therefore, this test may lead to an intrinsic selection bias. Moreover, despite our investigation including a large population of infertile and fertile subjects, those showing a positive MAR test were relatively few, hence the associations found need to be confirmed in larger studies. Finally, due to the cross-sectional nature of the study, neither a causality hypothesis nor a mechanistic model can be inferred.
The present study also has several strengths. Firstly, the study systematically evaluated several clinical, seminal and genital tract CDUS parameters in two cohorts (males of infertile and fertile couples). Secondly, we report for the first time a topographic localization of the male genital tract associated with MAR test positivity, as assessed by CDUS. Thirdly, we investigated the associations of different MAR test-related variables, including MAR test ≥ 50% for which SpermMAR test shows a high specificity (Comhaire et al., 1988) . Fourthly, this study considers some possible confounders, such as age and life-style factors. Finally, this study simultaneously examined several end-points within the same population, allowing a valid comparison of the co-prevalence of the parameters and supporting their possible association with MAR test positivity.
Conclusions
A positive MAR test correlates with CDUS epididymal abnormalities, a history of epididymitis and high sIL-8 levels, suggestive of chronic epididymal inflammation. In addition, MAR test positivity is associated with higher LH but not altered testosterone or FSH levels or CDUS testicular abnormalities. Overall, our data suggest that ASA positivity depends not so much on a direct testis injury, but mainly on an epididymal inflammation, which might extend to the testicular interstitium inducing a compensated Leydig cells impairment but not tubular damage. In our cohort, the detection of MAR test positivity was higher in males of infertile couples than in fertile men, irrespective of conventional semen parameters. This result supports a role of ASA in couple infertility, probably not by reducing semen parameters, but by impairing steps in the fertilization process.
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